Di Giacomo (Imi): "Search on Melanoma for New Treatment Strategies in Resistant"
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.5 Articles
5 Articles
canaledieci.it
The research, at this moment, is focusing on an important aspect: understanding those mechanisms that make patients resistant to treatments that we have available and identifying biomarkers that actually help us to better select patients and save unnecessary toxicity to patients who will not benefit from it. Another aspect [...]
(Adnkronos) - "Research at this time is focusing on an important aspect: understanding those mechanisms that make patients resistant to
The median survival of patients with metastatic melanoma was about 6 months; today more than 50% of patients are alive 10 years after the diagnosis, often without disease and, in a good percentage of cases, without therapy. The difference was made by two strategies adopted by a [...] L'articolo Mandalà (Imi): "More than 50% of patients with live melanoma 10 years after the diagnosis" comes from Rec News.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
